Supernus Pharmaceuticals Inventory Turnover Ratio 2011-2023 | SUPN

Supernus Pharmaceuticals inventory turnover ratio from 2011 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Supernus Pharmaceuticals Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.604B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.855B 5.36
Dr Reddy's Laboratories (RDY) India $12.352B 19.53
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.278B 0.00
Bausch Health Cos (BHC) Canada $3.150B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.995B 13.66
Taysha Gene Therapies (TSHA) United States $0.430B 0.00
Generation Bio (GBIO) United States $0.200B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.063B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00